Yu Mi Hye, Lee Jae Young, Kim Hae Ri, Kim Bo Ram, Park Eun-Joo, Kim Hoe Suk, Han Joon Koo, Choi Byung Ihn
Department of Radiology, Konkuk University Medical Center, Seoul 05030, Korea.
Department of Radiology, Seoul National University Hospital, Seoul 03080, Korea.
Korean J Radiol. 2016 Sep-Oct;17(5):779-88. doi: 10.3348/kjr.2016.17.5.779. Epub 2016 Aug 23.
To investigate whether high-intensity focused ultrasound (HIFU) combined with microbubbles enhances the therapeutic effects of chemotherapy.
A pancreatic cancer xenograft model was established using BALB/c nude mice and luciferase-expressing human pancreatic cancer cells. Mice were randomly assigned to five groups according to treatment: control (n = 10), gemcitabine alone (GEM; n = 12), HIFU with microbubbles (HIFU + MB, n = 11), combined HIFU and gemcitabine (HIGEM; n = 12), and HIGEM + MB (n = 13). After three weekly treatments, apoptosis rates were evaluated using the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay in two mice per group. Tumor volume and bioluminescence were monitored using high-resolution 3D ultrasound imaging and in vivo bioluminescence imaging for eight weeks in the remaining mice.
The HIGEM + MB group showed significantly higher apoptosis rates than the other groups (p < 0.05) and exhibited the slowest tumor growth. From week 5, the tumor-volume-ratio relative to the baseline tumor volume was significantly lower in the HIGEM + MB group than in the control, GEM, and HIFU + MB groups (p < 0.05). Despite visible distinction, the HIGEM and HIGEM + MB groups showed no significant differences.
High-intensity focused ultrasound combined with microbubbles enhances the therapeutic effects of gemcitabine chemotherapy in a pancreatic cancer xenograft model.
研究高强度聚焦超声(HIFU)联合微泡是否能增强化疗的治疗效果。
使用BALB/c裸鼠和表达荧光素酶的人胰腺癌细胞建立胰腺癌异种移植模型。根据治疗方法将小鼠随机分为五组:对照组(n = 10)、单纯吉西他滨组(GEM;n = 12)、HIFU联合微泡组(HIFU + MB,n = 11)、HIFU联合吉西他滨组(HIGEM;n = 12)和HIGEM + MB组(n = 13)。每周治疗三次后,每组选取两只小鼠,采用末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法评估凋亡率。对其余小鼠使用高分辨率3D超声成像和体内生物发光成像监测肿瘤体积和生物发光情况,持续八周。
HIGEM + MB组的凋亡率显著高于其他组(p < 0.05),且肿瘤生长最慢。从第5周起,HIGEM + MB组相对于基线肿瘤体积的肿瘤体积比显著低于对照组、GEM组和HIFU + MB组(p < 0.05)。尽管有明显差异,但HIGEM组和HIGEM + MB组之间无显著差异。
在胰腺癌异种移植模型中,高强度聚焦超声联合微泡可增强吉西他滨化疗的治疗效果。